Tender Touch Rehab Servs., LLC v. Brighten At Bryn Mawr
Decision Date | 13 June 2014 |
Docket Number | Civil Action No. 11–7016. |
Citation | 26 F.Supp.3d 376 |
Court | U.S. District Court — Eastern District of Pennsylvania |
Parties | TENDER TOUCH REHAB SERVICES, LLC, Plaintiff, v. BRIGHTEN AT BRYN MAWR, Brighten at Ambler, Brighten Health Group, LLC, Bryn Mawr Health Care Group, LLC, Ambler Healthcare Group, LLC, Chatau Senior Services, LLC, Saber Healthcare Group, Saber Healthcare Holdings, LLC, Aviv Healthcare Properties, LP, John Does 1–10, and ABC Corporations 1–10, Defendants. |
Bruce S. Luckman, Sherman Silverstein, Moorestown, NJ, Steven D. Gorelick, Garfunkel Wild PC, Hackensack, NJ, for Plaintiff.
Eric E. Reed, Fox Rothschild LLP, Philadelphia, PA, for Defendants.
Presently before this Court is Defendants Saber Healthcare Group, Saber Healthcare Holdings, LLC, Bryn Mawr Healthcare Group, LLC(collectively, “Saber”), and BHG Aviv LLC's (“Aviv”)1Motion for Summary Judgment in their favor on all claims asserted by PlaintiffTender Touch Rehab Services, LLC(“Plaintiff”).In its Complaint, Plaintiff claims that Defendants Brighten at Bryn Mawr, Brighten at Ambler, and other related entities are liable to it for payment of performed services under theories of breach of contract, account stated, promissory estoppel, unjust enrichment, and breach of the implied covenant of good faith and fair dealing.Plaintiff alleges that Saber is responsible for Brighten's breaches under successor liability theories, and that Saber and Aviv are liable for civil conspiracy.Upon consideration of the parties' motions with briefs and exhibits, this Court will deny Defendants' motion in all respects for the reasons set forth below.
Plaintiff submits that this “action arises out of Defendants' breach of the parties' agreements and failure to pay Tender Touch for therapy services provided to the nursing home residents of Brighten–Bryn Mawr and Brighten–Ambler.”(Compl. 1.)The relevant facts are as follows.
Brighten at Bryn Mawr is the registered fictitious name of Chateau Senior Services, LLC, which formerly operated a nursing home at 956 Railroad Avenue, Bryn Mawr, Pennsylvania.Brighten at Ambler is the registered fictitious name of Ambler Senior Services, LLC, which formerly operated a nursing home at 32 South Bethlehem Pike, Ambler, Pennsylvania.Brighten at Bryn Mawr, Brighten at Ambler, and related entities (collectively, “Brighten”) were all part of the Brighten Health Group.(LandenbergerDep. 39:4–10.)
On February 9, 2007, Brighten, as Lessee, and Aviv as Lessor, entered into a Master Lease.(Defs.' Ex. F, Master Lease.)Under the lease's terms, Brighten leased from Aviv the land, facilities, and personal property used to operate, inter alia,“a 160–bed nursing facility on land commonly known as Brighten at Bryn Mawr, 956 Railroad Avenue, Bryn Mawr, Pennsylvania, 19010,” and “a 100–bed nursing facility on land commonly known as Brighten at Ambler, located at 32 South Bethlehem Pike, Ambler, Pennsylvania 19002”).2(Id. at D02364)(emphasis added).As stated in the lease, Aviv was the contract purchaser of Brighten at Bryn Mawr and Brighten at Ambler, and owned all “personal property” at the facilities, including furnishings, furniture, equipment, and fixtures.(Id. at D02364–65.)The lease also gave Aviv a first lien paramount to all others, subject to any Mortgage/Underlying Lease made by Lessor, on every right and interest of Lessee in and to the lease, and on “any furnishings, equipment, fixtures, accounts receivable, certificates of need, licenses, provider agreements, certifications or other property of any kind belonging to Lessee and used in connection with the Lease or located at the Demised Premises.”3(Id. at D02377.)The Master Lease provided as follows in the event of Brighten's default under the lease:
(Id. at D02376.)
The Master Lease included a provision, Article 36, for the transfer of operations upon termination of the lease.Article 36 provides, in relevant part:
To continue reading
Request your trialUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology
